| Financial Year |
March 31 2023 |
| Monetary Funds |
1,752,919,237.10 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,154,049.79 |
| Accounts Receivable |
629,050,994.82 |
| Advances to Suppliers |
70,838,538.14 |
| Other Receivables |
100,765,727.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
869,524,800.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,720,726.98 |
| Total Current Assets |
3,579,330,862.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
210,275,578.38 |
| Investment Properties |
22,386,630.02 |
| Fixed Assetes |
1,648,204,403.09 |
| Under-construction Projects |
414,340,704.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
172,794,830.91 |
| R&D expenses |
-- |
| Goodwill |
578,796,538.56 |
| Long-Term Deferred and Prepaid Expenses |
9,748,261.05 |
| Deferred Income Tax Assets |
28,713,039.32 |
| Other Non-Current Assets |
167,466,243.23 |
| Sub-Total of Non-Current Assets |
3,338,216,427.02 |
| Total Assets |
6,917,547,289.10 |
| Short-Term Loans |
34,101,854.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
101,784,280.00 |
| Accounts Payable |
325,897,833.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,590,062.59 |
| Taxes Payable |
39,693,589.47 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
274,726,864.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
99,080,225.25 |
| Other Current Liabilities |
3,162,331.67 |
| Sub-Total of Current Liabilities |
1,002,202,204.44 |
| Long-term Loans |
195,203,347.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
398,812.24 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
264,166,895.85 |
| Total Liabilities |
1,266,369,100.29 |
| Paid-In Capital(Or Share Stock) |
989,204,866.00 |
| Capital Surplus |
1,802,717,543.92 |
| Surplus Reserve |
340,322,491.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,452,572,370.57 |
| Minority Stockholder's Interest |
46,178,659.63 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,604,999,529.18 |
| Owner's Equity（Stockholder's Equity） |
5,651,178,188.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,917,547,289.10 |
